News for Sanofi Stock (SNY)

Should Value Investors Buy Sanofi (SNY) Stock?

Zacks Investment Research • 10/14/24

French government seeking job guarantees from Sanofi over Doliprane production sites

Reuters • 10/14/24

Sanofi in Talks to Sell Controlling Stake in Consumer Health Arm to CD&R

WSJ • 10/11/24

Sanofi in talks to sell consumer healthcare business that makes Dulcolax

Market Watch • 10/11/24

Sanofi in talks to sell 50% stake in consumer health business to CD&R

Reuters • 10/11/24

Press Release: Sanofi in discussions to sell a controlling stake in Opella

GlobeNewsWire • 10/11/24

CD&R nears deal to buy Sanofi's consumer unit for $16 bln, Bloomberg News reports

Reuters • 10/10/24

Denali-Sanofi scraps mid-stage study for multiple sclerosis drug

Reuters • 10/10/24

Press Release: New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants

GlobeNewsWire • 10/09/24

Zacks Industry Outlook Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer

Zacks Investment Research • 10/08/24

5 Large Drug Stocks to Watch From a Thriving Industry

Zacks Investment Research • 10/07/24

Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reports

Reuters • 10/04/24

Recordati buys rights to rare immune disorder drug from Sanofi for $825 mln

Reuters • 10/04/24

Sanofi, Regeneron's Dupixent Gets FDA Approval for COPD

Zacks Investment Research • 09/30/24

Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD

Investopedia • 09/27/24

FDA Approves Regeneron/Sanofi's Blockbuster Dupixent For Smoker's Lung Disease

Benzinga • 09/27/24

Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD

WSJ • 09/27/24

US FDA approves Sanofi-Regeneron's Dupixent for 'smoker's lung'

Reuters • 09/27/24

Press Release: Dupixent approved in the US as the first-ever biologic medicine for patients with COPD

GlobeNewsWire • 09/27/24

Press Release: Dupixent approved in China as the first-ever biologic medicine for patients with COPD

GlobeNewsWire • 09/27/24

Are Investors Undervaluing Sanofi (SNY) Right Now?

Zacks Investment Research • 09/26/24

Buy These 5 Big Drug Stocks to Boost Your Portfolio's Health

Zacks Investment Research • 09/26/24

Press Release: Availability of the Q3 2024 Aide mémoire

GlobeNewsWire • 09/26/24

Sanofi gets two bids valuing its consumer health unit at about $17 billion, Bloomberg News reports

Reuters • 09/24/24

Sanofi Injects $27M In Neurology Drug Developer Ventyx Biosciences

Benzinga • 09/23/24